Ask Me Anything about AmyloSENS - Dr. Sudhir Paul and Michael Rae

Michael Rae (Science Writer for SENS Research Foundation) asks Dr. Sudhir Paul (CSO, Covalent Biosciences) about his AmyloSENS area of research. Dr. Paul is an extramural researcher for SENS Research Foundation. This video is part of our End of Year Campaign 2022 | Week 7: AmyloSENS | www.sens.org/eoy2022

[@SirTenenbaum]

Their research on catalytic antibodies (as opposed to binding antibodies) is so cool! Dr. Paul's specific assessment at 24:19 of aduhelm and lecanemab and how catabodies may be a considerably superior approach was extremely informative.

[@FroggyTWrite]

it's nice to see you folks posting more often

[@SENSRF]

Thank you for your kind words! We'll definitely be looking into posting more interviews with our thought leaders, scientists, and researchers so more people can learn about the exciting developments in longevity science! Stay tuned!

[@tintin_999]

Liz Parish and BioViva should start offering Amyloid Beta Catabody gene therapy treatment for Alzheimers down in Colombia.